-
Add to Cart The item has been addedHPA055237-100ULSigma Aldrich
ANTI-LRRC36 ANTIBODY PRODUCED IN RABBIT (C15-1461-944)
Price: $1,013.20List Price: $1,125.78Immunogen leucine rich repeat containing 36 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization -
Add to Cart The item has been addedHPA058479-100ULSigma Aldrich
ANTI-LRRC36 ANTIBODY PRODUCED IN RABBIT (C15-1462-959)
Price: $1,013.20List Price: $1,125.78Immunogen leucine rich repeat containing 36 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization -
Add to Cart The item has been addedHPA042121-100ULSigma Aldrich
ANTI-LRRC37A ANTIBODY PRODUCED IN RABBIT (C15-1457-073)
Price: $1,013.20List Price: $1,125.78Immunogen leucine rich repeat containing 37A Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization -
Add to Cart The item has been addedHPA043056-100ULSigma Aldrich
ANTI-LRRC37A ANTIBODY PRODUCED IN RABBIT (C15-1457-501)
Price: $1,013.20List Price: $1,125.78Immunogen leucine rich repeat containing 37A Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization -
Add to Cart The item has been addedHPA045090-100ULSigma Aldrich
ANTI-LRRC37A2 ANTIBODY PRODUCED IN RABBIT (C15-1458-403)
Price: $1,013.20List Price: $1,125.78Immunogen leucine rich repeat containing 37, member A2 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive -
Add to Cart The item has been addedHPA049080-100ULImmunogen leucine rich repeat containing 37, member A2 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive -
Add to Cart The item has been addedHPA015135-100ULLRRC37B (leucine rich repeat containing 37B) gene is localized to human chromosome 17q. The encoded protein contains LRR motifs in the N-terminal, which are responsible for protein-ligand binding. -
Add to Cart The item has been addedHPA015568-100ULImmunogen Leucine-rich repeat-containing protein 3B precursor recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and -
Add to Cart The item has been addedHPA071271-100ULImmunogen leucine rich repeat containing 3C Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization -
Add to Cart The item has been addedABN414Leucine-rich repeat-containing protein 4, or LRRC4, also known as Nasopharyngeal carcinoma-associated gene 14 protein or Netrin-G2 ligand (NGL-2), and encoded by the gene LRRC4/BAG, is a synaptic adhesion protein that regulates the formation of -
Add to Cart The item has been addedHPA050537-100ULSigma Aldrich
ANTI-LRRC42 ANTIBODY PRODUCED IN RABBIT (C15-1460-333)
Price: $1,013.20List Price: $1,125.78Immunogen leucine rich repeat containing 42 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are -
Add to Cart The item has been addedHPA064581-100ULImmunogen leucine rich repeat containing 42 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization
